PDCD1 and neoplasm: This was further confirmed by a striking reduction in the final tumor volumes in the anti-PD-1-treated cohort (p < 0.001, Fig. 9B).Proteomic profiling by LC-MS/MS revealed a distinct protein expression pattern between the two groups (Fig. 9C).